Lauxera Capital Partners

LUMICKS delivers state of the art technologies for the study of biology and cancer at the single-molecule and single-cell level.

Lifen is in compliance with the regulations in force and the recommendations of the HAS and the CNIL. Lifen aims to facilitate communication between health professionals while ensuring maximum security .Lifen acts as a sub-contractor to the physician or healthcare facility and does not own the data it hosts.

OrganOx Limited develops device known as Metra to store livers outside the body at normal body temperature. It engages in the research and study for test and transplant of livers. The company’s products are used to preserve the livers before transplantations. OrganOx Limited was incorporated in 2008 and is based in the Oxford, United Kingdom.

At caresyntax, your core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable, enterprise-level data analytics.

Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.

At caresyntax, your core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable, enterprise-level data analytics.

Reapplix A/S manufactures device for cell therapy that helps patients in wound healing. It offers 3C Patch, a triple layer patch that consists of fibrin for moisture retention and strength, platelets for growth factor release, and leucocytes to orchestrate wound healing and to fight infection. The company was formerly known as Reapplix ApS and changed its name to Reapplix A/S in December 2018. Reapplix A/S was founded in 2008 and is based in Birkerød, Denmark with an additional office in Southlake, Texas.

Natural Cycles offers a contraceptive app, spearheading digital contraception, a new category in female reproductive health. Users measure their basal body temperature in the morning and the app computes the temperature (and other relevant data like levels of luteinizing hormone) through an algorithm to calculate whether they are fertile or not. Natural Cycles’ subscription product relies on an algorithmic method to predict which days women are fertile during their monthly cycle — with an in-app color-coded calendar informing users if they could have unprotected sex on a given day or not. Women using the app are required to measure and input their body temperature daily using a basal thermometer. Natural Cycles relies on this and other individual data inputs to algorithmically calculate the probability of the user being fertile on each day in her cycle.

BioLamina AB engages in the development, manufacture, marketing, and sale of laminin cell culture products worldwide. The company offers a range of defined human recombinant laminin matrices that help to culture stem cells and tissue-specific cells, allowing to control and further develop cell research. Its products are used in human ES cell culturing, mouse ES cell culturing, beta cell-islets creation, single cell ES cell culturing, and human ES cells clonal culturing applications. BioLamina AB has a strategic collaboration with CEVEC Pharmaceuticals GmbH. The company was founded in 2009 and is based in Sundbyberg, Sweden.